We are always looking for exceptional talented people to join our company. If you have qualities that could complement our team, do not hesitate to apply!

About VERAXA Biotech

Veraxa Biotech GmbH is a young spin-off of the EMBL (European Molecular Biology Laboratory) in Heidelberg and specializes in the rapid and functional screening of antibodies using droplet-based microfluidic technology as well in the engineering of antibodies to yield superior antibody-drug-conjugates (ADC). Compared to current antibody screening methods, Veraxa’s technology enables the quantitative and rapid recognition of antibody functions in target cells for the first time. This will significantly shorten preclinical development times for therapeutic antibodies and allow patients to be treated earlier. Our ADC technology enables us to site-specifically install multiple toxic payloads on different sites of the antibody applying the fastest labeling method known today, making our technology outstanding compared to competitors on the market.